Mesotherapy Comprehensive Study by Type (Fillers Kits, Solution Kits, Chemical Peels, Anti-Ageing Masks, Devices), Application (Anti-Ageing and Wrinkle Treatment, Facial Rejuvenation, Stretch Marks, Acne and Scar Treatment, Fat Loss, Hair Loss), Distribution Channel (Hospitals, Dermatology Clinics, Cosmetic Clinics, Others), End-User (Men, Women) Players and Region - Global Market Outlook to 2032

Mesotherapy Market by XX Submarkets | Forecast Years 2025-2032  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Mesotherapy
Mesotherapy is a procedure that involves injecting vitamins, enzymes, hormones, and plant extracts into the skin to renew it and remove unwanted fat. Mesotherapy is a non-invasive or minimally invasive cosmetic procedure. As an aesthetic choice, consumers prefer minimally invasive procedures that take less time, are less unpleasant and require little or no recovery time. These elements are significant in propelling the mesotherapy market forward. Most mesotherapy products, like as lotions, masks, and peels, are non-invasive, whereas mesotherapy with solution kits, mesotherapy guns, and needles and cannulas are minimally invasive procedures. Because most regions have local manufacturers, mesotherapy items are readily available. The continents with the most manufacturers are Europe and East Asia. In order to expand their geographic reach and maximize income creation in the mesotherapy industry, most manufacturers additionally serve to consumers through online product selling platforms. Mesotherapy has a high adoption rate among athletes, who use it to relieve pain in various portions of their bodies. They can get better outcomes in less time, allowing them to get back on the field sooner. Furthermore, the popularity of this treatment process has grown due to lower costs, particularly in fat reduction operations. Mesotherapy is a popular treatment option.

AttributesDetails
Study Period2020-2032
Base Year2024
UnitValue (USD Million)


The market for Mesotherapy is highly competitive with several global as well as local players in the market. The global players are trying various strategies such as product innovation and using various marketing strategies to gain a higher market share. Analyst at AMA Research estimates that European Players will contribute the maximum growth to Global Mesotherapy market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Laboratoires FILORGA SA (France), Institute Bcn (Spain), Mesoskinline (Denmark), Koru Pharmaceuticals Co., Ltd. (Malaysia), Fusion Meso (Spain), TOSKANI COSMETICS (Spain), Dr. Korman Laboratories Ltd. (United States), Ostar Beauty Sci-Tech Co Ltd. (China), Skin Tech Pharma Group (Spain) and Galderma (India) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Revitacare (France), Dermedics International (Germany) and Others.

Segmentation Overview
AMA Research has segmented the market of Global Mesotherapy market by Type (Fillers Kits, Solution Kits, Chemical Peels, Anti-Ageing Masks and Devices), Application (Anti-Ageing and Wrinkle Treatment, Facial Rejuvenation, Stretch Marks, Acne and Scar Treatment, Fat Loss and Hair Loss) and Region.



On the basis of geography, the market of Mesotherapy has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Distribution Channel, the sub-segment i.e. Hospitals will boost the Mesotherapy market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End-User, the sub-segment i.e. Men will boost the Mesotherapy market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Mesotherapy is Widely Adopted as an Alternative to Liposuction

Market Growth Drivers:
Several Medical Benefits Associated and Growing Urbanisation and Changing Lifestyles

Challenges:
High Cost of Treatment and Still Considered as a Relatively New Method in the Field of Skin Treatment

Opportunities:
Growing Research and Development Activities and High Adoption Rate among Athletes as they undergo this Procedure to Lower Pain in their Body Parts

In December 2021, With hemp seed oil as the main ingredient, Koru Pharmaceuticals launched a new professional cosmetic line, Mesohemp. The firm's latest brand, Mesohemp, is a skincare range that contains a native Korean species of hemp called green hemp – a hybrid of imported cannabis from the Netherlands and Korean hemp.


Key Target Audience
Manufacturers of Mesotherapy Products, Suppliers of Mesotherapy Products, E-Commerce Companies, Medical Research Institutes, Hospitals and Pharmaceutical Companies

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Fillers Kits
  • Solution Kits
  • Chemical Peels
  • Anti-Ageing Masks
  • Devices
By Application
  • Anti-Ageing and Wrinkle Treatment
  • Facial Rejuvenation
  • Stretch Marks
  • Acne and Scar Treatment
  • Fat Loss
  • Hair Loss
By Distribution Channel
  • Hospitals
  • Dermatology Clinics
  • Cosmetic Clinics
  • Others

By End-User
  • Men
  • Women

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Several Medical Benefits Associated
      • 3.2.2. Growing Urbanisation and Changing Lifestyles
    • 3.3. Market Challenges
      • 3.3.1. High Cost of Treatment
      • 3.3.2. Still Considered as a Relatively New Method in the Field of Skin Treatment
    • 3.4. Market Trends
      • 3.4.1. Mesotherapy is Widely Adopted as an Alternative to Liposuction
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Mesotherapy, by Type, Application, Distribution Channel, End-User and Region (value and price ) (2019-2024)
    • 5.1. Introduction
    • 5.2. Global Mesotherapy (Value)
      • 5.2.1. Global Mesotherapy by: Type (Value)
        • 5.2.1.1. Fillers Kits
        • 5.2.1.2. Solution Kits
        • 5.2.1.3. Chemical Peels
        • 5.2.1.4. Anti-Ageing Masks
        • 5.2.1.5. Devices
      • 5.2.2. Global Mesotherapy by: Application (Value)
        • 5.2.2.1. Anti-Ageing and Wrinkle Treatment
        • 5.2.2.2. Facial Rejuvenation
        • 5.2.2.3. Stretch Marks
        • 5.2.2.4. Acne and Scar Treatment
        • 5.2.2.5. Fat Loss
        • 5.2.2.6. Hair Loss
      • 5.2.3. Global Mesotherapy by: Distribution Channel (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Dermatology Clinics
        • 5.2.3.3. Cosmetic Clinics
        • 5.2.3.4. Others
      • 5.2.4. Global Mesotherapy by: End-User (Value)
        • 5.2.4.1. Men
        • 5.2.4.2. Women
      • 5.2.5. Global Mesotherapy Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Mesotherapy (Price)
      • 5.3.1. Global Mesotherapy by: Type (Price)
  • 6. Mesotherapy: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2024)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Laboratoires FILORGA SA (France)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Institute Bcn (Spain)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Mesoskinline (Denmark)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Koru Pharmaceuticals Co., Ltd. (Malaysia)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Fusion Meso (Spain)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. TOSKANI COSMETICS (Spain)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Dr. Korman Laboratories Ltd. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Ostar Beauty Sci-Tech Co Ltd. (China)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Skin Tech Pharma Group (Spain)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Galderma (India)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Mesotherapy Sale, by Type, Application, Distribution Channel, End-User and Region (value and price ) (2027-2032)
    • 7.1. Introduction
    • 7.2. Global Mesotherapy (Value)
      • 7.2.1. Global Mesotherapy by: Type (Value)
        • 7.2.1.1. Fillers Kits
        • 7.2.1.2. Solution Kits
        • 7.2.1.3. Chemical Peels
        • 7.2.1.4. Anti-Ageing Masks
        • 7.2.1.5. Devices
      • 7.2.2. Global Mesotherapy by: Application (Value)
        • 7.2.2.1. Anti-Ageing and Wrinkle Treatment
        • 7.2.2.2. Facial Rejuvenation
        • 7.2.2.3. Stretch Marks
        • 7.2.2.4. Acne and Scar Treatment
        • 7.2.2.5. Fat Loss
        • 7.2.2.6. Hair Loss
      • 7.2.3. Global Mesotherapy by: Distribution Channel (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Dermatology Clinics
        • 7.2.3.3. Cosmetic Clinics
        • 7.2.3.4. Others
      • 7.2.4. Global Mesotherapy by: End-User (Value)
        • 7.2.4.1. Men
        • 7.2.4.2. Women
      • 7.2.5. Global Mesotherapy Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Mesotherapy (Price)
      • 7.3.1. Global Mesotherapy by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Mesotherapy: by Type(USD Million)
  • Table 2. Mesotherapy Fillers Kits , by Region USD Million (2019-2024)
  • Table 3. Mesotherapy Solution Kits , by Region USD Million (2019-2024)
  • Table 4. Mesotherapy Chemical Peels , by Region USD Million (2019-2024)
  • Table 5. Mesotherapy Anti-Ageing Masks , by Region USD Million (2019-2024)
  • Table 6. Mesotherapy Devices , by Region USD Million (2019-2024)
  • Table 7. Mesotherapy: by Application(USD Million)
  • Table 8. Mesotherapy Anti-Ageing and Wrinkle Treatment , by Region USD Million (2019-2024)
  • Table 9. Mesotherapy Facial Rejuvenation , by Region USD Million (2019-2024)
  • Table 10. Mesotherapy Stretch Marks , by Region USD Million (2019-2024)
  • Table 11. Mesotherapy Acne and Scar Treatment , by Region USD Million (2019-2024)
  • Table 12. Mesotherapy Fat Loss , by Region USD Million (2019-2024)
  • Table 13. Mesotherapy Hair Loss , by Region USD Million (2019-2024)
  • Table 14. Mesotherapy: by Distribution Channel(USD Million)
  • Table 15. Mesotherapy Hospitals , by Region USD Million (2019-2024)
  • Table 16. Mesotherapy Dermatology Clinics , by Region USD Million (2019-2024)
  • Table 17. Mesotherapy Cosmetic Clinics , by Region USD Million (2019-2024)
  • Table 18. Mesotherapy Others , by Region USD Million (2019-2024)
  • Table 19. Mesotherapy: by End-User(USD Million)
  • Table 20. Mesotherapy Men , by Region USD Million (2019-2024)
  • Table 21. Mesotherapy Women , by Region USD Million (2019-2024)
  • Table 22. South America Mesotherapy, by Country USD Million (2019-2024)
  • Table 23. South America Mesotherapy, by Type USD Million (2019-2024)
  • Table 24. South America Mesotherapy, by Application USD Million (2019-2024)
  • Table 25. South America Mesotherapy, by Distribution Channel USD Million (2019-2024)
  • Table 26. South America Mesotherapy, by End-User USD Million (2019-2024)
  • Table 27. Brazil Mesotherapy, by Type USD Million (2019-2024)
  • Table 28. Brazil Mesotherapy, by Application USD Million (2019-2024)
  • Table 29. Brazil Mesotherapy, by Distribution Channel USD Million (2019-2024)
  • Table 30. Brazil Mesotherapy, by End-User USD Million (2019-2024)
  • Table 31. Argentina Mesotherapy, by Type USD Million (2019-2024)
  • Table 32. Argentina Mesotherapy, by Application USD Million (2019-2024)
  • Table 33. Argentina Mesotherapy, by Distribution Channel USD Million (2019-2024)
  • Table 34. Argentina Mesotherapy, by End-User USD Million (2019-2024)
  • Table 35. Rest of South America Mesotherapy, by Type USD Million (2019-2024)
  • Table 36. Rest of South America Mesotherapy, by Application USD Million (2019-2024)
  • Table 37. Rest of South America Mesotherapy, by Distribution Channel USD Million (2019-2024)
  • Table 38. Rest of South America Mesotherapy, by End-User USD Million (2019-2024)
  • Table 39. Asia Pacific Mesotherapy, by Country USD Million (2019-2024)
  • Table 40. Asia Pacific Mesotherapy, by Type USD Million (2019-2024)
  • Table 41. Asia Pacific Mesotherapy, by Application USD Million (2019-2024)
  • Table 42. Asia Pacific Mesotherapy, by Distribution Channel USD Million (2019-2024)
  • Table 43. Asia Pacific Mesotherapy, by End-User USD Million (2019-2024)
  • Table 44. China Mesotherapy, by Type USD Million (2019-2024)
  • Table 45. China Mesotherapy, by Application USD Million (2019-2024)
  • Table 46. China Mesotherapy, by Distribution Channel USD Million (2019-2024)
  • Table 47. China Mesotherapy, by End-User USD Million (2019-2024)
  • Table 48. Japan Mesotherapy, by Type USD Million (2019-2024)
  • Table 49. Japan Mesotherapy, by Application USD Million (2019-2024)
  • Table 50. Japan Mesotherapy, by Distribution Channel USD Million (2019-2024)
  • Table 51. Japan Mesotherapy, by End-User USD Million (2019-2024)
  • Table 52. India Mesotherapy, by Type USD Million (2019-2024)
  • Table 53. India Mesotherapy, by Application USD Million (2019-2024)
  • Table 54. India Mesotherapy, by Distribution Channel USD Million (2019-2024)
  • Table 55. India Mesotherapy, by End-User USD Million (2019-2024)
  • Table 56. South Korea Mesotherapy, by Type USD Million (2019-2024)
  • Table 57. South Korea Mesotherapy, by Application USD Million (2019-2024)
  • Table 58. South Korea Mesotherapy, by Distribution Channel USD Million (2019-2024)
  • Table 59. South Korea Mesotherapy, by End-User USD Million (2019-2024)
  • Table 60. Taiwan Mesotherapy, by Type USD Million (2019-2024)
  • Table 61. Taiwan Mesotherapy, by Application USD Million (2019-2024)
  • Table 62. Taiwan Mesotherapy, by Distribution Channel USD Million (2019-2024)
  • Table 63. Taiwan Mesotherapy, by End-User USD Million (2019-2024)
  • Table 64. Australia Mesotherapy, by Type USD Million (2019-2024)
  • Table 65. Australia Mesotherapy, by Application USD Million (2019-2024)
  • Table 66. Australia Mesotherapy, by Distribution Channel USD Million (2019-2024)
  • Table 67. Australia Mesotherapy, by End-User USD Million (2019-2024)
  • Table 68. Rest of Asia-Pacific Mesotherapy, by Type USD Million (2019-2024)
  • Table 69. Rest of Asia-Pacific Mesotherapy, by Application USD Million (2019-2024)
  • Table 70. Rest of Asia-Pacific Mesotherapy, by Distribution Channel USD Million (2019-2024)
  • Table 71. Rest of Asia-Pacific Mesotherapy, by End-User USD Million (2019-2024)
  • Table 72. Europe Mesotherapy, by Country USD Million (2019-2024)
  • Table 73. Europe Mesotherapy, by Type USD Million (2019-2024)
  • Table 74. Europe Mesotherapy, by Application USD Million (2019-2024)
  • Table 75. Europe Mesotherapy, by Distribution Channel USD Million (2019-2024)
  • Table 76. Europe Mesotherapy, by End-User USD Million (2019-2024)
  • Table 77. Germany Mesotherapy, by Type USD Million (2019-2024)
  • Table 78. Germany Mesotherapy, by Application USD Million (2019-2024)
  • Table 79. Germany Mesotherapy, by Distribution Channel USD Million (2019-2024)
  • Table 80. Germany Mesotherapy, by End-User USD Million (2019-2024)
  • Table 81. France Mesotherapy, by Type USD Million (2019-2024)
  • Table 82. France Mesotherapy, by Application USD Million (2019-2024)
  • Table 83. France Mesotherapy, by Distribution Channel USD Million (2019-2024)
  • Table 84. France Mesotherapy, by End-User USD Million (2019-2024)
  • Table 85. Italy Mesotherapy, by Type USD Million (2019-2024)
  • Table 86. Italy Mesotherapy, by Application USD Million (2019-2024)
  • Table 87. Italy Mesotherapy, by Distribution Channel USD Million (2019-2024)
  • Table 88. Italy Mesotherapy, by End-User USD Million (2019-2024)
  • Table 89. United Kingdom Mesotherapy, by Type USD Million (2019-2024)
  • Table 90. United Kingdom Mesotherapy, by Application USD Million (2019-2024)
  • Table 91. United Kingdom Mesotherapy, by Distribution Channel USD Million (2019-2024)
  • Table 92. United Kingdom Mesotherapy, by End-User USD Million (2019-2024)
  • Table 93. Netherlands Mesotherapy, by Type USD Million (2019-2024)
  • Table 94. Netherlands Mesotherapy, by Application USD Million (2019-2024)
  • Table 95. Netherlands Mesotherapy, by Distribution Channel USD Million (2019-2024)
  • Table 96. Netherlands Mesotherapy, by End-User USD Million (2019-2024)
  • Table 97. Rest of Europe Mesotherapy, by Type USD Million (2019-2024)
  • Table 98. Rest of Europe Mesotherapy, by Application USD Million (2019-2024)
  • Table 99. Rest of Europe Mesotherapy, by Distribution Channel USD Million (2019-2024)
  • Table 100. Rest of Europe Mesotherapy, by End-User USD Million (2019-2024)
  • Table 101. MEA Mesotherapy, by Country USD Million (2019-2024)
  • Table 102. MEA Mesotherapy, by Type USD Million (2019-2024)
  • Table 103. MEA Mesotherapy, by Application USD Million (2019-2024)
  • Table 104. MEA Mesotherapy, by Distribution Channel USD Million (2019-2024)
  • Table 105. MEA Mesotherapy, by End-User USD Million (2019-2024)
  • Table 106. Middle East Mesotherapy, by Type USD Million (2019-2024)
  • Table 107. Middle East Mesotherapy, by Application USD Million (2019-2024)
  • Table 108. Middle East Mesotherapy, by Distribution Channel USD Million (2019-2024)
  • Table 109. Middle East Mesotherapy, by End-User USD Million (2019-2024)
  • Table 110. Africa Mesotherapy, by Type USD Million (2019-2024)
  • Table 111. Africa Mesotherapy, by Application USD Million (2019-2024)
  • Table 112. Africa Mesotherapy, by Distribution Channel USD Million (2019-2024)
  • Table 113. Africa Mesotherapy, by End-User USD Million (2019-2024)
  • Table 114. North America Mesotherapy, by Country USD Million (2019-2024)
  • Table 115. North America Mesotherapy, by Type USD Million (2019-2024)
  • Table 116. North America Mesotherapy, by Application USD Million (2019-2024)
  • Table 117. North America Mesotherapy, by Distribution Channel USD Million (2019-2024)
  • Table 118. North America Mesotherapy, by End-User USD Million (2019-2024)
  • Table 119. United States Mesotherapy, by Type USD Million (2019-2024)
  • Table 120. United States Mesotherapy, by Application USD Million (2019-2024)
  • Table 121. United States Mesotherapy, by Distribution Channel USD Million (2019-2024)
  • Table 122. United States Mesotherapy, by End-User USD Million (2019-2024)
  • Table 123. Canada Mesotherapy, by Type USD Million (2019-2024)
  • Table 124. Canada Mesotherapy, by Application USD Million (2019-2024)
  • Table 125. Canada Mesotherapy, by Distribution Channel USD Million (2019-2024)
  • Table 126. Canada Mesotherapy, by End-User USD Million (2019-2024)
  • Table 127. Mexico Mesotherapy, by Type USD Million (2019-2024)
  • Table 128. Mexico Mesotherapy, by Application USD Million (2019-2024)
  • Table 129. Mexico Mesotherapy, by Distribution Channel USD Million (2019-2024)
  • Table 130. Mexico Mesotherapy, by End-User USD Million (2019-2024)
  • Table 131. Mesotherapy: by Type(USD/Units)
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Mesotherapy: by Type(USD Million)
  • Table 143. Mesotherapy Fillers Kits , by Region USD Million (2027-2032)
  • Table 144. Mesotherapy Solution Kits , by Region USD Million (2027-2032)
  • Table 145. Mesotherapy Chemical Peels , by Region USD Million (2027-2032)
  • Table 146. Mesotherapy Anti-Ageing Masks , by Region USD Million (2027-2032)
  • Table 147. Mesotherapy Devices , by Region USD Million (2027-2032)
  • Table 148. Mesotherapy: by Application(USD Million)
  • Table 149. Mesotherapy Anti-Ageing and Wrinkle Treatment , by Region USD Million (2027-2032)
  • Table 150. Mesotherapy Facial Rejuvenation , by Region USD Million (2027-2032)
  • Table 151. Mesotherapy Stretch Marks , by Region USD Million (2027-2032)
  • Table 152. Mesotherapy Acne and Scar Treatment , by Region USD Million (2027-2032)
  • Table 153. Mesotherapy Fat Loss , by Region USD Million (2027-2032)
  • Table 154. Mesotherapy Hair Loss , by Region USD Million (2027-2032)
  • Table 155. Mesotherapy: by Distribution Channel(USD Million)
  • Table 156. Mesotherapy Hospitals , by Region USD Million (2027-2032)
  • Table 157. Mesotherapy Dermatology Clinics , by Region USD Million (2027-2032)
  • Table 158. Mesotherapy Cosmetic Clinics , by Region USD Million (2027-2032)
  • Table 159. Mesotherapy Others , by Region USD Million (2027-2032)
  • Table 160. Mesotherapy: by End-User(USD Million)
  • Table 161. Mesotherapy Men , by Region USD Million (2027-2032)
  • Table 162. Mesotherapy Women , by Region USD Million (2027-2032)
  • Table 163. South America Mesotherapy, by Country USD Million (2027-2032)
  • Table 164. South America Mesotherapy, by Type USD Million (2027-2032)
  • Table 165. South America Mesotherapy, by Application USD Million (2027-2032)
  • Table 166. South America Mesotherapy, by Distribution Channel USD Million (2027-2032)
  • Table 167. South America Mesotherapy, by End-User USD Million (2027-2032)
  • Table 168. Brazil Mesotherapy, by Type USD Million (2027-2032)
  • Table 169. Brazil Mesotherapy, by Application USD Million (2027-2032)
  • Table 170. Brazil Mesotherapy, by Distribution Channel USD Million (2027-2032)
  • Table 171. Brazil Mesotherapy, by End-User USD Million (2027-2032)
  • Table 172. Argentina Mesotherapy, by Type USD Million (2027-2032)
  • Table 173. Argentina Mesotherapy, by Application USD Million (2027-2032)
  • Table 174. Argentina Mesotherapy, by Distribution Channel USD Million (2027-2032)
  • Table 175. Argentina Mesotherapy, by End-User USD Million (2027-2032)
  • Table 176. Rest of South America Mesotherapy, by Type USD Million (2027-2032)
  • Table 177. Rest of South America Mesotherapy, by Application USD Million (2027-2032)
  • Table 178. Rest of South America Mesotherapy, by Distribution Channel USD Million (2027-2032)
  • Table 179. Rest of South America Mesotherapy, by End-User USD Million (2027-2032)
  • Table 180. Asia Pacific Mesotherapy, by Country USD Million (2027-2032)
  • Table 181. Asia Pacific Mesotherapy, by Type USD Million (2027-2032)
  • Table 182. Asia Pacific Mesotherapy, by Application USD Million (2027-2032)
  • Table 183. Asia Pacific Mesotherapy, by Distribution Channel USD Million (2027-2032)
  • Table 184. Asia Pacific Mesotherapy, by End-User USD Million (2027-2032)
  • Table 185. China Mesotherapy, by Type USD Million (2027-2032)
  • Table 186. China Mesotherapy, by Application USD Million (2027-2032)
  • Table 187. China Mesotherapy, by Distribution Channel USD Million (2027-2032)
  • Table 188. China Mesotherapy, by End-User USD Million (2027-2032)
  • Table 189. Japan Mesotherapy, by Type USD Million (2027-2032)
  • Table 190. Japan Mesotherapy, by Application USD Million (2027-2032)
  • Table 191. Japan Mesotherapy, by Distribution Channel USD Million (2027-2032)
  • Table 192. Japan Mesotherapy, by End-User USD Million (2027-2032)
  • Table 193. India Mesotherapy, by Type USD Million (2027-2032)
  • Table 194. India Mesotherapy, by Application USD Million (2027-2032)
  • Table 195. India Mesotherapy, by Distribution Channel USD Million (2027-2032)
  • Table 196. India Mesotherapy, by End-User USD Million (2027-2032)
  • Table 197. South Korea Mesotherapy, by Type USD Million (2027-2032)
  • Table 198. South Korea Mesotherapy, by Application USD Million (2027-2032)
  • Table 199. South Korea Mesotherapy, by Distribution Channel USD Million (2027-2032)
  • Table 200. South Korea Mesotherapy, by End-User USD Million (2027-2032)
  • Table 201. Taiwan Mesotherapy, by Type USD Million (2027-2032)
  • Table 202. Taiwan Mesotherapy, by Application USD Million (2027-2032)
  • Table 203. Taiwan Mesotherapy, by Distribution Channel USD Million (2027-2032)
  • Table 204. Taiwan Mesotherapy, by End-User USD Million (2027-2032)
  • Table 205. Australia Mesotherapy, by Type USD Million (2027-2032)
  • Table 206. Australia Mesotherapy, by Application USD Million (2027-2032)
  • Table 207. Australia Mesotherapy, by Distribution Channel USD Million (2027-2032)
  • Table 208. Australia Mesotherapy, by End-User USD Million (2027-2032)
  • Table 209. Rest of Asia-Pacific Mesotherapy, by Type USD Million (2027-2032)
  • Table 210. Rest of Asia-Pacific Mesotherapy, by Application USD Million (2027-2032)
  • Table 211. Rest of Asia-Pacific Mesotherapy, by Distribution Channel USD Million (2027-2032)
  • Table 212. Rest of Asia-Pacific Mesotherapy, by End-User USD Million (2027-2032)
  • Table 213. Europe Mesotherapy, by Country USD Million (2027-2032)
  • Table 214. Europe Mesotherapy, by Type USD Million (2027-2032)
  • Table 215. Europe Mesotherapy, by Application USD Million (2027-2032)
  • Table 216. Europe Mesotherapy, by Distribution Channel USD Million (2027-2032)
  • Table 217. Europe Mesotherapy, by End-User USD Million (2027-2032)
  • Table 218. Germany Mesotherapy, by Type USD Million (2027-2032)
  • Table 219. Germany Mesotherapy, by Application USD Million (2027-2032)
  • Table 220. Germany Mesotherapy, by Distribution Channel USD Million (2027-2032)
  • Table 221. Germany Mesotherapy, by End-User USD Million (2027-2032)
  • Table 222. France Mesotherapy, by Type USD Million (2027-2032)
  • Table 223. France Mesotherapy, by Application USD Million (2027-2032)
  • Table 224. France Mesotherapy, by Distribution Channel USD Million (2027-2032)
  • Table 225. France Mesotherapy, by End-User USD Million (2027-2032)
  • Table 226. Italy Mesotherapy, by Type USD Million (2027-2032)
  • Table 227. Italy Mesotherapy, by Application USD Million (2027-2032)
  • Table 228. Italy Mesotherapy, by Distribution Channel USD Million (2027-2032)
  • Table 229. Italy Mesotherapy, by End-User USD Million (2027-2032)
  • Table 230. United Kingdom Mesotherapy, by Type USD Million (2027-2032)
  • Table 231. United Kingdom Mesotherapy, by Application USD Million (2027-2032)
  • Table 232. United Kingdom Mesotherapy, by Distribution Channel USD Million (2027-2032)
  • Table 233. United Kingdom Mesotherapy, by End-User USD Million (2027-2032)
  • Table 234. Netherlands Mesotherapy, by Type USD Million (2027-2032)
  • Table 235. Netherlands Mesotherapy, by Application USD Million (2027-2032)
  • Table 236. Netherlands Mesotherapy, by Distribution Channel USD Million (2027-2032)
  • Table 237. Netherlands Mesotherapy, by End-User USD Million (2027-2032)
  • Table 238. Rest of Europe Mesotherapy, by Type USD Million (2027-2032)
  • Table 239. Rest of Europe Mesotherapy, by Application USD Million (2027-2032)
  • Table 240. Rest of Europe Mesotherapy, by Distribution Channel USD Million (2027-2032)
  • Table 241. Rest of Europe Mesotherapy, by End-User USD Million (2027-2032)
  • Table 242. MEA Mesotherapy, by Country USD Million (2027-2032)
  • Table 243. MEA Mesotherapy, by Type USD Million (2027-2032)
  • Table 244. MEA Mesotherapy, by Application USD Million (2027-2032)
  • Table 245. MEA Mesotherapy, by Distribution Channel USD Million (2027-2032)
  • Table 246. MEA Mesotherapy, by End-User USD Million (2027-2032)
  • Table 247. Middle East Mesotherapy, by Type USD Million (2027-2032)
  • Table 248. Middle East Mesotherapy, by Application USD Million (2027-2032)
  • Table 249. Middle East Mesotherapy, by Distribution Channel USD Million (2027-2032)
  • Table 250. Middle East Mesotherapy, by End-User USD Million (2027-2032)
  • Table 251. Africa Mesotherapy, by Type USD Million (2027-2032)
  • Table 252. Africa Mesotherapy, by Application USD Million (2027-2032)
  • Table 253. Africa Mesotherapy, by Distribution Channel USD Million (2027-2032)
  • Table 254. Africa Mesotherapy, by End-User USD Million (2027-2032)
  • Table 255. North America Mesotherapy, by Country USD Million (2027-2032)
  • Table 256. North America Mesotherapy, by Type USD Million (2027-2032)
  • Table 257. North America Mesotherapy, by Application USD Million (2027-2032)
  • Table 258. North America Mesotherapy, by Distribution Channel USD Million (2027-2032)
  • Table 259. North America Mesotherapy, by End-User USD Million (2027-2032)
  • Table 260. United States Mesotherapy, by Type USD Million (2027-2032)
  • Table 261. United States Mesotherapy, by Application USD Million (2027-2032)
  • Table 262. United States Mesotherapy, by Distribution Channel USD Million (2027-2032)
  • Table 263. United States Mesotherapy, by End-User USD Million (2027-2032)
  • Table 264. Canada Mesotherapy, by Type USD Million (2027-2032)
  • Table 265. Canada Mesotherapy, by Application USD Million (2027-2032)
  • Table 266. Canada Mesotherapy, by Distribution Channel USD Million (2027-2032)
  • Table 267. Canada Mesotherapy, by End-User USD Million (2027-2032)
  • Table 268. Mexico Mesotherapy, by Type USD Million (2027-2032)
  • Table 269. Mexico Mesotherapy, by Application USD Million (2027-2032)
  • Table 270. Mexico Mesotherapy, by Distribution Channel USD Million (2027-2032)
  • Table 271. Mexico Mesotherapy, by End-User USD Million (2027-2032)
  • Table 272. Mesotherapy: by Type(USD/Units)
  • Table 273. Research Programs/Design for This Report
  • Table 274. Key Data Information from Secondary Sources
  • Table 275. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Mesotherapy: by Type USD Million (2019-2024)
  • Figure 5. Global Mesotherapy: by Application USD Million (2019-2024)
  • Figure 6. Global Mesotherapy: by Distribution Channel USD Million (2019-2024)
  • Figure 7. Global Mesotherapy: by End-User USD Million (2019-2024)
  • Figure 8. South America Mesotherapy Share (%), by Country
  • Figure 9. Asia Pacific Mesotherapy Share (%), by Country
  • Figure 10. Europe Mesotherapy Share (%), by Country
  • Figure 11. MEA Mesotherapy Share (%), by Country
  • Figure 12. North America Mesotherapy Share (%), by Country
  • Figure 13. Global Mesotherapy: by Type USD/Units (2019-2024)
  • Figure 14. Global Mesotherapy share by Players 2024 (%)
  • Figure 15. Global Mesotherapy share by Players (Top 3) 2024(%)
  • Figure 16. Global Mesotherapy share by Players (Top 5) 2024(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Laboratoires FILORGA SA (France) Revenue, Net Income and Gross profit
  • Figure 19. Laboratoires FILORGA SA (France) Revenue: by Geography 2024
  • Figure 20. Institute Bcn (Spain) Revenue, Net Income and Gross profit
  • Figure 21. Institute Bcn (Spain) Revenue: by Geography 2024
  • Figure 22. Mesoskinline (Denmark) Revenue, Net Income and Gross profit
  • Figure 23. Mesoskinline (Denmark) Revenue: by Geography 2024
  • Figure 24. Koru Pharmaceuticals Co., Ltd. (Malaysia) Revenue, Net Income and Gross profit
  • Figure 25. Koru Pharmaceuticals Co., Ltd. (Malaysia) Revenue: by Geography 2024
  • Figure 26. Fusion Meso (Spain) Revenue, Net Income and Gross profit
  • Figure 27. Fusion Meso (Spain) Revenue: by Geography 2024
  • Figure 28. TOSKANI COSMETICS (Spain) Revenue, Net Income and Gross profit
  • Figure 29. TOSKANI COSMETICS (Spain) Revenue: by Geography 2024
  • Figure 30. Dr. Korman Laboratories Ltd. (United States) Revenue, Net Income and Gross profit
  • Figure 31. Dr. Korman Laboratories Ltd. (United States) Revenue: by Geography 2024
  • Figure 32. Ostar Beauty Sci-Tech Co Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 33. Ostar Beauty Sci-Tech Co Ltd. (China) Revenue: by Geography 2024
  • Figure 34. Skin Tech Pharma Group (Spain) Revenue, Net Income and Gross profit
  • Figure 35. Skin Tech Pharma Group (Spain) Revenue: by Geography 2024
  • Figure 36. Galderma (India) Revenue, Net Income and Gross profit
  • Figure 37. Galderma (India) Revenue: by Geography 2024
  • Figure 38. Global Mesotherapy: by Type USD Million (2027-2032)
  • Figure 39. Global Mesotherapy: by Application USD Million (2027-2032)
  • Figure 40. Global Mesotherapy: by Distribution Channel USD Million (2027-2032)
  • Figure 41. Global Mesotherapy: by End-User USD Million (2027-2032)
  • Figure 42. South America Mesotherapy Share (%), by Country
  • Figure 43. Asia Pacific Mesotherapy Share (%), by Country
  • Figure 44. Europe Mesotherapy Share (%), by Country
  • Figure 45. MEA Mesotherapy Share (%), by Country
  • Figure 46. North America Mesotherapy Share (%), by Country
  • Figure 47. Global Mesotherapy: by Type USD/Units (2027-2032)
List of companies from research coverage that are profiled in the study
  • Laboratoires FILORGA SA (France)
  • Institute Bcn (Spain)
  • Mesoskinline (Denmark)
  • Koru Pharmaceuticals Co., Ltd. (Malaysia)
  • Fusion Meso (Spain)
  • TOSKANI COSMETICS (Spain)
  • Dr. Korman Laboratories Ltd. (United States)
  • Ostar Beauty Sci-Tech Co Ltd. (China)
  • Skin Tech Pharma Group (Spain)
  • Galderma (India)
Additional players considered in the study are as follows:
Revitacare (France) , Dermedics International (Germany) , Others
Select User Access Type

Key Highlights of Report


Jan 2025 156 Pages 81 Tables Base Year: 2024 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Laboratoires FILORGA SA (France), Institute Bcn (Spain), Mesoskinline (Denmark), Koru Pharmaceuticals Co., Ltd. (Malaysia), Fusion Meso (Spain), TOSKANI COSMETICS (Spain), Dr. Korman Laboratories Ltd. (United States), Ostar Beauty Sci-Tech Co Ltd. (China), Skin Tech Pharma Group (Spain) and Galderma (India) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Mesotherapy is Widely Adopted as an Alternative to Liposuction" is seen as one of major influencing trends for Mesotherapy Market during projected period 2024-2032.
The Mesotherapy market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Mesotherapy Market Report?